Recebe uma resposta deste empregador
O teu currículo e carta de apresentação, adaptados exatamente ao que estão a contratar.
Secura Bio is seeking a Key Account Manager for the Southern Atlantic region. This remote US-based role covers Georgia, Alabama, North Carolina, and South Carolina, reporting to the VP of US Sales, Market Access and Operations.
You will promote Copiktra, educate providers, and execute territory plans across oncology practices. Responsibilities include delivering balanced clinical messaging, managing travel, budgeting, and collaborating with Medical Affairs and cross-functional teams to meet
Key Account Manager - Southern Atlantic
Location: Remote (United States)
Department: Field Sales
About the Role
The Key Account Manager (KAM) is responsible for promoting Copiktra in a fair and balanced manner consistent Secura Bio’s policies. The KAM will promote Copiktra (and any other approved drugs) in a manner consistent with approved indications to targeted customers including Medical Oncologists, Hematologists and Multi-Disciplinary team. The KAM will be responsible for improving customer awareness and on-label sales of Copiktra across the entirety of their assigned territory. The KAM will appropriately engage cross-functional partners, including Market Development Managers and the Market Access team, as well as Medical Science Liaisons, to effectively meet customer needs and to ensure customer questions are appropriately addressed.
Employment Type
Full-time
Reports To
VP, US Sales, Market Access and Operations
Key Responsibilities
Required Qualifications
Territory: Georgia, Alabama, North Carolina, South Carolina
Salary: $185,000 - $226,000
Secura Bio was established in 2019 with a singular mission: to close the gap between innovative oncology therapies and the patients who need them most. Our high-touch approach is informed by our decades of experience shaping the impact of oncology’s largest clinical and market opportunities. We know that true impact comes from personalization and an unwavering commitment to serve patients and expand the possibilities of life-prolonging oncology medicines.